{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:20:53Z","timestamp":1770816053415,"version":"3.50.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-02896-x","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:38:55Z","timestamp":1757572735000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identifying drug targets and evaluating KLK3-targeted inhibitors for prostate cancer using in-silico and in-vitro approaches"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9246-0850","authenticated-orcid":false,"given":"Imran","family":"Zafar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaista","family":"Shafiq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adil","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Mohany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Shafiq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Amjad","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najeeb Ullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"issue":"2","key":"2896_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/pros.23934","volume":"80","author":"AK Miyahira","year":"2020","unstructured":"Miyahira AK, Sharp A, Ellis L, Jones J, Kaochar S, Larman HB, et al. Prostate cancer research: the next generation; report from the 2019 Coffey-Holden prostate cancer academy meeting. Prostate. 2020;80(2):113\u201332.","journal-title":"Prostate"},{"issue":"18","key":"2896_CR2","doi-asserted-by":"publisher","first-page":"4412","DOI":"10.3390\/cancers14184412","volume":"14","author":"LO Gonzalez","year":"2022","unstructured":"Gonzalez LO, Eiro N, Fraile M, Beridze N, Escaf AR, Escaf S, et al. Prostate cancer tumor stroma: responsibility in tumor biology, diagnosis and treatment. Cancers. 2022;14(18):4412.","journal-title":"Cancers"},{"issue":"6","key":"2896_CR3","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.eururo.2021.07.024","volume":"80","author":"H Van Poppel","year":"2021","unstructured":"Van Poppel H, Roobol MJ, Chapple CR, Catto JW, N\u2019Dow J, S\u00f8nksen J, et al. Prostate-specific antigen testing as part of a risk-adapted early detection strategy for prostate cancer: European Association of Urology position and recommendations for 2021. Eur Urol. 2021;80(6):703\u201311.","journal-title":"Eur Urol"},{"issue":"1","key":"2896_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5334\/aogh.2607","volume":"86","author":"S Hassanipour","year":"2020","unstructured":"Hassanipour S, Delam H, Arab-Zozani M, Abdzadeh E, Hosseini SA, Nikbakht HA, et al. Survival rate of prostate cancer in Asian countries: a systematic review and meta-analysis. Ann Glob Health. 2020;86(1):2.","journal-title":"Ann Glob Health"},{"key":"2896_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/bs.acc.2019.08.004","volume":"95","author":"S Baskaran","year":"2020","unstructured":"Baskaran S, Selvam MKP, Agarwal A. Exosomes of male reproduction. Adv Clin Chem. 2020;95:149\u201363.","journal-title":"Adv Clin Chem"},{"key":"2896_CR6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.radonc.2020.10.027","volume":"153","author":"RN Kandalan","year":"2020","unstructured":"Kandalan RN, Nguyen D, Rezaeian NH, Barrag\u00e1n-Montero AM, Breedveld S, Namuduri K, et al. Dose prediction with deep learning for prostate cancer radiation therapy: model adaptation to different treatment planning practices. Radiother Oncol. 2020;153:228\u201335.","journal-title":"Radiother Oncol"},{"issue":"2","key":"2896_CR7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.22270\/jddt.v11i2.4758","volume":"11","author":"A Habib","year":"2021","unstructured":"Habib A, Jaffar G, Khalid MS, Hussain Z, Zainab SW, Ashraf Z, et al. Risk factors associated with prostate cancer. J Drug Deliv Ther. 2021;11(2):188\u201393.","journal-title":"J Drug Deliv Ther"},{"issue":"22","key":"2896_CR8","doi-asserted-by":"publisher","first-page":"14257","DOI":"10.3390\/ijms232214257","volume":"23","author":"S Wasim","year":"2022","unstructured":"Wasim S, Lee SY, Kim J. Complexities of prostate cancer. Int J Mol Sci. 2022;23(22):14257.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2896_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s13167-020-00214-1","volume":"11","author":"R Kucera","year":"2020","unstructured":"Kucera R, Pecen L, Topolcan O, Dahal AR, Costigliola V, Giordano FA, Golubnitschaja O. Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensional solutions. EPMA J. 2020;11(3):399\u2013418.","journal-title":"EPMA J"},{"issue":"2","key":"2896_CR10","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.3390\/curroncol30020178","volume":"30","author":"CV Berenguer","year":"2023","unstructured":"Berenguer CV, Pereira F, C\u00e2mara JS, Pereira JA. Underlying features of prostate cancer\u2014statistics, risk factors, and emerging methods for its diagnosis. Curr Oncol. 2023;30(2):2300\u201321.","journal-title":"Curr Oncol"},{"issue":"8","key":"2896_CR11","doi-asserted-by":"publisher","first-page":"424","DOI":"10.5694\/mja2.51722","volume":"217","author":"IS Williams","year":"2022","unstructured":"Williams IS, McVey A, Perera S, O\u2019Brien JS, Kostos L, Chen K, et al. Modern paradigms for prostate cancer detection and management. Med J Aust. 2022;217(8):424\u201333.","journal-title":"Med J Aust"},{"issue":"24","key":"2896_CR12","doi-asserted-by":"publisher","first-page":"13537","DOI":"10.3390\/ijms222413537","volume":"22","author":"Y Yan","year":"2021","unstructured":"Yan Y, Yeon SY, Qian C, You S, Yang W. On the road to accurate protein biomarkers in prostate cancer diagnosis and prognosis: current status and future advances. Int J Mol Sci. 2021;22(24):13537.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"2896_CR13","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41585-020-0349-1","volume":"17","author":"MM Kouspou","year":"2020","unstructured":"Kouspou MM, Fong JE, Brew N, Hsiao ST, Davidson SL, Choyke PL, et al. The movember prostate cancer landscape analysis: an assessment of unmet research needs. Nat Rev Urol. 2020;17(9):499\u2013512.","journal-title":"Nat Rev Urol"},{"issue":"6","key":"2896_CR14","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00439-011-0981-1","volume":"129","author":"Z Kote-Jarai","year":"2011","unstructured":"Kote-Jarai Z, Amin Al Olama A, Leongamornlert D, Tymrakiewicz M, Saunders E, Guy M, et al. Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript. Hum Genet. 2011;129(6):687\u201394.","journal-title":"Hum Genet"},{"issue":"6","key":"2896_CR15","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/carcin\/bgr050","volume":"32","author":"KL Penney","year":"2011","unstructured":"Penney KL, Schumacher FR, Kraft P, Mucci LA, Sesso HD, Ma J, et al. Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels. Carcinogenesis. 2011;32(6):853\u20139.","journal-title":"Carcinogenesis"},{"key":"2896_CR16","doi-asserted-by":"publisher","first-page":"105263","DOI":"10.1016\/j.bspc.2023.105263","volume":"86","author":"I Zafar","year":"2023","unstructured":"Zafar I, Anwar S, Yousaf W, Nisa FU, Kausar T, ul Ain Q, et al. Reviewing methods of deep learning for intelligent healthcare systems in genomics and biomedicine. Biomed Signal Process Control. 2023;86:105263.","journal-title":"Biomed Signal Process Control"},{"issue":"6","key":"2896_CR17","doi-asserted-by":"publisher","first-page":"102186","DOI":"10.1016\/j.jksus.2022.102186","volume":"34","author":"HM Ahmad","year":"2022","unstructured":"Ahmad HM, Abrar M, Izhar O, Zafar I, Rather MA, Alanazi AM, et al. Characterization of fenugreek and its natural compounds targeting AKT-1 protein in cancer: pharmacophore, virtual screening, and MD simulation techniques. J King Saud Univ Sci. 2022;34(6):102186.","journal-title":"J King Saud Univ Sci"},{"key":"2896_CR18","doi-asserted-by":"publisher","first-page":"1173624","DOI":"10.3389\/fchem.2023.1173624","volume":"11","author":"S Ali","year":"2023","unstructured":"Ali S, Ali U, Qamar A, Zafar I, Yaqoob M, Ain QU, et al. Predicting the effects of rare genetic variants on oncogenic signaling pathways: a computational analysis of HRAS protein function. Front Chem. 2023;11:1173624.","journal-title":"Front Chem"},{"issue":"11","key":"2896_CR19","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.3390\/cells9112342","volume":"9","author":"DJ Turnham","year":"2020","unstructured":"Turnham DJ, Bullock N, Dass MS, Staffurth JN, Pearson HB. The PTEN conundrum: how to target PTEN-deficient prostate cancer. Cells. 2020;9(11):2342.","journal-title":"Cells"},{"key":"2896_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fonc.2015.00024","volume":"5","author":"M Milella","year":"2015","unstructured":"Milella M, Falcone I, Conciatori F, Incani UC, Del Curatolo A, Inzerilli N, et al. PTEN: multiple functions in human malignant tumors. Front Oncol. 2015;5:24.","journal-title":"Front Oncol"},{"key":"2896_CR21","doi-asserted-by":"crossref","unstructured":"Shiota M (2021) Oxidative stress and prostate cancer. In: Cancer, pp\u00a015\u201326. Academic Press.","DOI":"10.1016\/B978-0-12-819547-5.00002-X"},{"issue":"9","key":"2896_CR22","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1158\/2159-8290.CD-20-1765","volume":"11","author":"A Papachristodoulou","year":"2021","unstructured":"Papachristodoulou A, Rodriguez-Calero A, Panja S, Margolskee E, Virk RK, Milner TA, et al. NKX3.1 localization to mitochondria suppresses prostate cancer initiation. Cancer Discov. 2021;11(9):2316\u201333.","journal-title":"Cancer Discov"},{"issue":"4","key":"2896_CR23","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrurol.2018.9","volume":"15","author":"T Jamaspishvili","year":"2018","unstructured":"Jamaspishvili T, Berman DM, Ross AE, Scher HI, De Marzo AM, Squire JA, Lotan TL. Clinical implications of PTEN loss in prostate cancer. Nat Rev Urol. 2018;15(4):222\u201334.","journal-title":"Nat Rev Urol"},{"key":"2896_CR24","doi-asserted-by":"publisher","first-page":"117955492094732","DOI":"10.1177\/1179554920947322","volume":"14","author":"\u00d6 G\u00fclhan","year":"2020","unstructured":"G\u00fclhan \u00d6, Mahi B. The role of AMACR, CD10, TMPRSS2-ERG, and p27 protein expression among different Gleason grades of prostatic adenocarcinoma on needle biopsy. Clin Med Insights Oncol. 2020;14:1179554920947322.","journal-title":"Clin Med Insights Oncol"},{"issue":"5","key":"2896_CR25","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/jar.12725","volume":"33","author":"S Mkabile","year":"2020","unstructured":"Mkabile S, Swartz L. Caregivers\u2019 and parents\u2019 explanatory models of intellectual disability in Khayelitsha, Cape Town, South Africa. J Appl Res Intellect Disabil. 2020;33(5):1026\u201337.","journal-title":"J Appl Res Intellect Disabil"},{"issue":"3","key":"2896_CR26","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1080\/07391102.2020.1824814","volume":"40","author":"BK Kumar","year":"2022","unstructured":"Kumar BK, Faheem N, Sekhar KVGC, Ojha R, Prajapati VK, Pai A, Murugesan S. Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases. J Biomol Struct Dyn. 2022;40(3):1363\u201386.","journal-title":"J Biomol Struct Dyn"},{"key":"2896_CR27","doi-asserted-by":"publisher","first-page":"11273149","DOI":"10.3389\/fchem.2023.1273149","volume":"11","author":"I Zafar","year":"2023","unstructured":"Zafar I, Safder A, Imran Afridi H, Riaz S, -ur-Rehman R, Unar A, et al. In silico and in vitro study of bioactive compounds of Nigella sativa for targeting neuropilins in breast cancer. Front Chem. 2023;11:11273149.","journal-title":"Front Chem"},{"key":"2896_CR28","doi-asserted-by":"publisher","first-page":"123026","DOI":"10.1016\/j.jorganchem.2024.123026","volume":"1007","author":"H Mouada","year":"2024","unstructured":"Mouada H, Lanez T, Zafar I. ROS scavenging, DNA binding and NADPH oxidase inhibition potential of N\u2019-Ferrocenylmethyl-N\u2019-phenylpropionohydrazide using cyclic voltammetry and molecular docking. J Organomet Chem. 2024;1007:123026.","journal-title":"J Organomet Chem"},{"issue":"1","key":"2896_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/cncr.32498","volume":"126","author":"A Bleyer","year":"2020","unstructured":"Bleyer A, Spreafico F, Barr R. Prostate cancer in young men: an emerging young adult and older adolescent challenge. Cancer. 2020;126(1):46\u201357.","journal-title":"Cancer"},{"issue":"3","key":"2896_CR30","doi-asserted-by":"publisher","first-page":"288","DOI":"10.5534\/wjmh.180040","volume":"37","author":"K Fujita","year":"2019","unstructured":"Fujita K, Nonomura N. Role of androgen receptor in prostate cancer: a review. World J Mens Health. 2019;37(3):288\u201395.","journal-title":"World J Mens Health"},{"issue":"4","key":"2896_CR31","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1080\/02763869.2020.1826228","volume":"39","author":"J White","year":"2020","unstructured":"White J. PubMed 2.0. Med Ref Serv Q. 2020;39(4):382\u20137.","journal-title":"Med Ref Serv Q"},{"key":"2896_CR32","doi-asserted-by":"publisher","first-page":"1169595","DOI":"10.3389\/frai.2023.1169595","volume":"6","author":"T Dave","year":"2023","unstructured":"Dave T, Athaluri SA, Singh S. ChatGPT in medicine: an overview of its applications, advantages, limitations, future prospects, and ethical considerations. Front Artif Intell. 2023;6:1169595.","journal-title":"Front Artif Intell"},{"issue":"2","key":"2896_CR33","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3390\/ijms23020897","volume":"23","author":"W Ratajczak","year":"2022","unstructured":"Ratajczak W, Lubkowski M, Lubkowska A. Heat shock proteins in benign prostatic hyperplasia and prostate cancer. Int J Mol Sci. 2022;23(2):897.","journal-title":"Int J Mol Sci"},{"issue":"D1","key":"2896_CR34","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"2896_CR35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2174\/1389203717666161028145848","volume":"18","author":"V N Uversky","year":"2017","unstructured":"N Uversky V, Na I, S Landau K, O Schenck R. Highly disordered proteins in prostate cancer. Curr Protein Pept Sci. 2017;18(5):453\u201381.","journal-title":"Curr Protein Pept Sci"},{"issue":"5","key":"2896_CR36","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1136\/amiajnl-2010-000055","volume":"18","author":"M Huang","year":"2011","unstructured":"Huang M, N\u00e9v\u00e9ol A, Lu Z. Recommending MeSH terms for annotating biomedical articles. J Am Med Inform Assoc. 2011;18(5):660\u20137.","journal-title":"J Am Med Inform Assoc"},{"key":"2896_CR37","doi-asserted-by":"publisher","first-page":"baaa037","DOI":"10.1093\/database\/baaa037","volume":"2020","author":"R Kishore","year":"2020","unstructured":"Kishore R, Arnaboldi V, Van Slyke CE, Chan J, Nash RS, Urbano JM, et al. Automated generation of gene summaries at the Alliance of Genome Resources. Database. 2020;2020:baaa037.","journal-title":"Database"},{"issue":"7","key":"2896_CR38","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1080\/07357907.2024.2373841","volume":"42","author":"R Kumar Kore","year":"2024","unstructured":"Kumar Kore R, Shirbhate E, Singh V, Mishra A, Veerasamy R, Rajak H. New investigational drug\u2019s targeting various molecular pathways for treatment of cervical cancer: current status and future prospects. Cancer Invest. 2024;42(7):627\u201342.","journal-title":"Cancer Invest"},{"issue":"1","key":"2896_CR39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The protein data bank. Nucleic Acids Res. 2000;28(1):235\u201342.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2896_CR40","doi-asserted-by":"publisher","first-page":"D488","DOI":"10.1093\/nar\/gkac1077","volume":"51","author":"SK Burley","year":"2023","unstructured":"Burley SK, Bhikadiya C, Bi C, Bittrich S, Chao H, Chen L, et al. RCSB Protein Data Bank (RCSB. org): delivery of experimentally-determined PDB structures alongside one million computed structure models of proteins from artificial intelligence\/machine learning. Nucleic Acids Res. 2023;51(D1):D488\u2013508.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2896_CR41","first-page":"82","volume":"40","author":"WL DeLano","year":"2002","unstructured":"DeLano WL. Pymol: an open-source molecular graphics tool. CCP4 Newsl Protein Crystallogr. 2002;40(1):82\u201392.","journal-title":"CCP4 Newsl Protein Crystallogr"},{"issue":"W1","key":"2896_CR42","doi-asserted-by":"publisher","first-page":"W174","DOI":"10.1093\/nar\/gkv342","volume":"43","author":"J Yang","year":"2015","unstructured":"Yang J, Zhang Y. I-TASSER server: new development for protein structure and function predictions. Nucleic Acids Res. 2015;43(W1):W174\u201381.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2896_CR43","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-2105-9-40","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinform. 2008;9(1):40.","journal-title":"BMC Bioinform"},{"issue":"W1","key":"2896_CR44","doi-asserted-by":"publisher","first-page":"W448","DOI":"10.1093\/nar\/gkv306","volume":"43","author":"CM Labb\u00e9","year":"2015","unstructured":"Labb\u00e9 CM, Rey J, Lagorce D, Vavru\u0161a M, Becot J, Sperandio O, et al. MTiOpenScreen: a web server for structure-based virtual screening. Nucleic Acids Res. 2015;43(W1):W448\u201354.","journal-title":"Nucleic Acids Res"},{"issue":"22","key":"2896_CR45","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1093\/bioinformatics\/btx491","volume":"33","author":"D Lagorce","year":"2017","unstructured":"Lagorce D, Bouslama L, Becot J, Miteva MA, Villoutreix BO. FAF-Drugs4: free ADME-tox filtering computations for chemical biology and early stages drug discovery. Bioinformatics. 2017;33(22):3658\u201360.","journal-title":"Bioinformatics"},{"issue":"D1","key":"2896_CR46","doi-asserted-by":"publisher","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","volume":"45","author":"A Gaulton","year":"2017","unstructured":"Gaulton A, Hersey A, Nowotka M, Bento AP, Chambers J, Mendez D, et al. The ChEMBL database in 2017. Nucleic Acids Res. 2017;45(D1):D945\u201354.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2896_CR47","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","volume":"52","author":"C Knox","year":"2024","unstructured":"Knox C, Wilson M, Klinger CM, Franklin M, Oler E, Wilson A, et al. DrugBank 6.0: the DrugBank knowledgebase for 2024. Nucleic Acids Res. 2024;52(D1):D1265\u201375.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2896_CR48","doi-asserted-by":"publisher","first-page":"D1137","DOI":"10.1093\/nar\/gkx1088","volume":"46","author":"VB Siramshetty","year":"2018","unstructured":"Siramshetty VB, Eckert OA, Gohlke BO, Goede A, Chen Q, Devarakonda P, et al. SuperDRUG2: a one stop resource for approved\/marketed drugs. Nucleic Acids Res. 2018;46(D1):D1137\u201343.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2896_CR49","first-page":"932","volume":"45","author":"O Ursu","year":"2016","unstructured":"Ursu O, Holmes J, Knockel J, Bologa CG, Yang JJ, Mathias SL, et al. DrugCentral: online drug compendium. Nucleic Acids Res. 2016;45(1):932\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2896_CR50","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46(D1):D1074\u201382.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2896_CR51","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455\u201361.","journal-title":"J Comput Chem"},{"issue":"1","key":"2896_CR52","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1021\/ci049714+","volume":"45","author":"JJ Irwin","year":"2005","unstructured":"Irwin JJ, Shoichet BK. ZINC\u2014a free database of commercially available compounds for virtual screening. J Chem Inf Model. 2005;45(1):177\u201382.","journal-title":"J Chem Inf Model"},{"issue":"W1","key":"2896_CR53","doi-asserted-by":"publisher","first-page":"W443","DOI":"10.1093\/nar\/gkv315","volume":"43","author":"S Salentin","year":"2015","unstructured":"Salentin S, Schreiber S, Haupt VJ, Adasme MF, Schroeder M. PLIP: fully automated protein\u2013ligand interaction profiler. Nucleic Acids Res. 2015;43(W1):W443\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"2896_CR54","doi-asserted-by":"publisher","first-page":"844","DOI":"10.3390\/membranes12090844","volume":"12","author":"S Sinha","year":"2022","unstructured":"Sinha S, Tam B, Wang SM. Applications of molecular dynamics simulation in protein study. Membranes. 2022;12(9):844.","journal-title":"Membranes"},{"issue":"4","key":"2896_CR55","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s11030-022-10522-5","volume":"27","author":"SS Mishra","year":"2023","unstructured":"Mishra SS, Kumar N, Karkara BB, Sharma CS, Kalra S. Identification of potential inhibitors of Zika virus targeting NS3 helicase using molecular dynamics simulations and DFT studies. Mol Diversity. 2023;27(4):1689\u2013701.","journal-title":"Mol Diversity"},{"issue":"6","key":"2896_CR56","doi-asserted-by":"publisher","first-page":"431","DOI":"10.4103\/ijp.ijp_111_22","volume":"54","author":"M Prajapat","year":"2022","unstructured":"Prajapat M, Sarma P, Shekhar N, Chauhan A, Kaur G, Bhattacharyya A, et al. Virtual screening and molecular dynamics simulation study of approved drugs as a binder to the linoleic acid binding site on spike protein of SARS-CoV-2 and double mutant (E484Q and L452R). Indian J Pharmacol. 2022;54(6):431\u201342.","journal-title":"Indian J Pharmacol"},{"key":"2896_CR57","doi-asserted-by":"crossref","unstructured":"Jeffers J, Reinders J, Sodani A. Optimizing classical molecular dynamics in LAMMPS. In: Intel Xeon Phi Processor High Performance Programming, pp\u00a0443\u2013470","DOI":"10.1016\/B978-0-12-809194-4.00020-X"},{"issue":"3","key":"2896_CR58","doi-asserted-by":"publisher","first-page":"e202401981","DOI":"10.1002\/cbdv.202401981","volume":"22","author":"S Rastogi","year":"2025","unstructured":"Rastogi S, Shekher Mishra S, Singh L, Kumar N. Identification of potential inhibitors of TGF\u03b2R1 for the treatment of cancer through structure-based virtual screening and molecular dynamics simulations. Chem Biodivers. 2025;22(3):e202401981.","journal-title":"Chem Biodivers"},{"issue":"8","key":"2896_CR59","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1080\/07391102.2019.1633407","volume":"38","author":"MA Rather","year":"2020","unstructured":"Rather MA, Dutta S, Guttula PK, Dhandare BC, Yusufzai SI, Zafar MI. Structural analysis, molecular docking and molecular dynamics simulations of G-protein-coupled receptor (kisspeptin) in fish. J Biomol Struct Dyn. 2020;38(8):2422\u201339.","journal-title":"J Biomol Struct Dyn"},{"key":"2896_CR60","doi-asserted-by":"publisher","first-page":"107855","DOI":"10.1016\/j.compbiolchem.2023.107855","volume":"104","author":"K Tabti","year":"2023","unstructured":"Tabti K, Ahmad I, Zafar I, Sbai A, Maghat H, Bouachrine M, Lakhlifi T. Profiling the structural determinants of pyrrolidine derivative as gelatinases (MMP-2 and MMP-9) inhibitors using in silico approaches. Comput Biol Chem. 2023;104:107855.","journal-title":"Comput Biol Chem"},{"issue":"18","key":"2896_CR61","doi-asserted-by":"publisher","first-page":"184908","DOI":"10.1063\/5.0007445","volume":"152","author":"SL Bore","year":"2020","unstructured":"Bore SL, Kolli HB, De Nicola A, Byshkin M, Kawakatsu T, Milano G, Cascella M. Hybrid particle-field molecular dynamics under constant pressure. J Chem Phys. 2020;152(18):184908.","journal-title":"J Chem Phys"},{"issue":"5","key":"2896_CR62","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/bip.22418","volume":"101","author":"G Paris","year":"2014","unstructured":"Paris G, Ramseyer C, Enescu M. A principal component analysis of the dynamics of subdomains and binding sites in human serum albumin. Biopolymers. 2014;101(5):561\u201372.","journal-title":"Biopolymers"},{"issue":"6","key":"2896_CR63","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/CAD.0000000000001297","volume":"33","author":"H Kurter","year":"2022","unstructured":"Kurter H, Mert-Ozupek N, Ellidokuz H, Calibasi-Kocal G. In-silico drug-likeness analysis, ADME properties, and molecular docking studies of cyanidin-3-arabinoside, pelargonidin-3-glucoside, and peonidin-3-arabinoside as natural anticancer compounds against acting receptor-like kinase 5 receptor. Anticancer Drugs. 2022;33(6):517\u201322.","journal-title":"Anticancer Drugs"},{"issue":"7","key":"2896_CR64","doi-asserted-by":"publisher","first-page":"e2418736","DOI":"10.1001\/jamanetworkopen.2024.18736","volume":"7","author":"J Stal","year":"2024","unstructured":"Stal J, Miller KA, Mullett TW, Boughey JC, Francescatti AB, Funk E, et al. Cancer survivorship care in the United States at facilities accredited by the Commission on Cancer. JAMA Netw Open. 2024;7(7):e2418736\u2013e2418736.","journal-title":"JAMA Netw Open"},{"key":"2896_CR65","doi-asserted-by":"publisher","unstructured":"Salama, JAS, Yahia DA, Ali MM, Elsadig AE, Hamid TA. Detection of androgen receptor gene polymorphism in sudanese patients of prostate cancer in khartoum state. J Cancer Tumour Int. https:\/\/doi.org\/10.9734\/JCTI\/2022\/V12I430184","DOI":"10.9734\/JCTI\/2022\/V12I430184"},{"issue":"3","key":"2896_CR66","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10555-019-09815-3","volume":"38","author":"A Moradi","year":"2019","unstructured":"Moradi A, Srinivasan S, Clements J, Batra J. Beyond the biomarker role: prostate-specific antigen (PSA) in the prostate cancer microenvironment. Cancer Metastasis Rev. 2019;38(3):333\u201346.","journal-title":"Cancer Metastasis Rev"},{"issue":"6","key":"2896_CR67","doi-asserted-by":"publisher","first-page":"101414","DOI":"10.1016\/j.jbc.2021.101414","volume":"297","author":"SC Lim","year":"2021","unstructured":"Lim SC, Geleta B, Maleki S, Richardson DR, Kova\u010devi\u0107 \u017d. The metastasis suppressor NDRG1 directly regulates androgen receptor signaling in prostate cancer. J Biol Chem. 2021;297(6):101414.","journal-title":"J Biol Chem"},{"issue":"2","key":"2896_CR68","first-page":"181","volume":"44","author":"N Bakhshandeh","year":"2023","unstructured":"Bakhshandeh N, Mohammadi M, Mohammadi P, Nazari E, Damchi M, Khodabandelu S, Mokhtari H. Increased expression of androgen receptor and PSA genes in LNCaP (prostate cancer) cell line due to high concentrations of EGCG, an active ingredient in green tea. Horm Mol Biol Clin Invest. 2023;44(2):181\u20136.","journal-title":"Horm Mol Biol Clin Invest"},{"issue":"11","key":"2896_CR69","doi-asserted-by":"publisher","first-page":"101211","DOI":"10.1016\/j.tranon.2021.101211","volume":"14","author":"F Pellegrino","year":"2021","unstructured":"Pellegrino F, Coghi A, Lavorgna G, Cazzaniga W, Guazzoni E, Locatelli I, et al. A mechanistic insight into the anti-metastatic role of the prostate specific antigen. Transl Oncol. 2021;14(11):101211.","journal-title":"Transl Oncol"},{"issue":"S7","key":"2896_CR70","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1002\/1097-0142(19950401)75:7+<2021::AID-CNCR2820751644>3.0.CO;2-R","volume":"75","author":"DM Peehl","year":"1995","unstructured":"Peehl DM. Prostate specific antigen role and function. Cancer. 1995;75(S7):2021\u20136.","journal-title":"Cancer"},{"issue":"5","key":"2896_CR71","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/carcin\/bgl236","volume":"28","author":"J Lai","year":"2007","unstructured":"Lai J, Kedda MA, Hinze K, Smith RL, Yaxley J, Spurdle AB, et al. PSA\/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility. Carcinogenesis. 2007;28(5):1032\u20139.","journal-title":"Carcinogenesis"},{"key":"2896_CR72","first-page":"505","volume":"11","author":"C MS","year":"2007","unstructured":"MS C. Role of androgen metabolism genes CYP1B1, PSA\/KLK3, and CYP11a in prostate cancer risk and aggressiveness. Cancer Epidemol Biomark Prev. 2007;11:505\u201312.","journal-title":"Cancer Epidemol Biomark Prev"},{"issue":"4","key":"2896_CR73","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/ijc.22365","volume":"120","author":"R Chmelar","year":"2007","unstructured":"Chmelar R, Buchanan G, Need EF, Tilley W, Greenberg NM. Androgen receptor coregulators and their involvement in the development and progression of prostate cancer. Int J Cancer. 2007;120(4):719\u201333.","journal-title":"Int J Cancer"},{"issue":"3","key":"2896_CR74","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ajur.2019.10.003","volume":"7","author":"RE Vickman","year":"2020","unstructured":"Vickman RE, Franco OE, Moline DC, Vander Griend DJ, Thumbikat P, Hayward SW. The role of the androgen receptor in prostate development and benign prostatic hyperplasia: a review. Asian J Urol. 2020;7(3):191\u2013202.","journal-title":"Asian J Urol"},{"issue":"1","key":"2896_CR75","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1023\/A:1026057402945","volume":"253","author":"B Chatterjee","year":"2003","unstructured":"Chatterjee B. The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer. Mol Cell Biochem. 2003;253(1):89\u2013101.","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"2896_CR76","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1210\/er.2009-0034","volume":"31","author":"MG Lawrence","year":"2010","unstructured":"Lawrence MG, Lai J, Clements JA. Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus. Endocr Rev. 2010;31(4):407\u201346.","journal-title":"Endocr Rev"},{"issue":"1","key":"2896_CR77","doi-asserted-by":"publisher","first-page":"31345","DOI":"10.1038\/s41598-024-82821-w","volume":"14","author":"RM Merrill","year":"2024","unstructured":"Merrill RM, Gibbons IS. Prostate-specific antigen testing in the United States during 2008\u20132022 in relation to the US preventive services task force recommendations. Sci Rep. 2024;14(1):31345.","journal-title":"Sci Rep"},{"issue":"8","key":"2896_CR78","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ng.882","volume":"43","author":"Z Kote-Jarai","year":"2011","unstructured":"Kote-Jarai Z, Olama AAA, Giles GG, Severi G, Schleutker J, Weischer M, et al. Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet. 2011;43(8):785\u201391.","journal-title":"Nat Genet"},{"issue":"17","key":"2896_CR79","doi-asserted-by":"publisher","first-page":"5983","DOI":"10.3390\/ijms21175983","volume":"21","author":"J Wei","year":"2020","unstructured":"Wei J, Hu M, Huang K, Lin S, Du H. Roles of proteoglycans and glycosaminoglycans in cancer development and progression. Int J Mol Sci. 2020;21(17):5983.","journal-title":"Int J Mol Sci"},{"key":"2896_CR80","doi-asserted-by":"publisher","first-page":"112401","DOI":"10.1016\/j.indcrop.2020.112401","volume":"150","author":"K Pal","year":"2020","unstructured":"Pal K, Chowdhury S, Dutta SK, Chakraborty S, Chakraborty M, Pandit GK, et al. Analysis of rhizome colour content, bioactive compound profiling and ex-situ conservation of turmeric genotypes (Curcuma longa L.) from sub-Himalayan terai region of India. Ind Crops Products. 2020;150:112401.","journal-title":"Ind Crops Products"},{"issue":"2","key":"2896_CR81","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3390\/ph14020157","volume":"14","author":"P Garcia-Oliveira","year":"2021","unstructured":"Garcia-Oliveira P, Otero P, Pereira AG, Chamorro F, Carpena M, Echave J, et al. Status and challenges of plant-anticancer compounds in cancer treatment. Pharmaceuticals. 2021;14(2):157.","journal-title":"Pharmaceuticals"},{"issue":"6","key":"2896_CR82","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3390\/antiox13060708","volume":"13","author":"MR Miranda","year":"2024","unstructured":"Miranda MR, Basilicata MG, Vestuto V, Aquino G, Marino P, Salviati E, et al. Anticancer therapies based on oxidative damage: Lycium barbarum inhibits the proliferation of MCF-7 cells by activating pyroptosis through endoplasmic reticulum stress. Antioxidants. 2024;13(6):708.","journal-title":"Antioxidants"},{"issue":"3","key":"2896_CR83","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3390\/separations10030215","volume":"10","author":"WY Teoh","year":"2023","unstructured":"Teoh WY, Yong YS, Razali FN, Stephenie S, Dawood Shah M, Tan JK, et al. LC-MS\/MS and GC-MS analysis for the identification of bioactive metabolites responsible for the antioxidant and antibacterial activities of Lygodium microphyllum (Cav.) R. Br. Separations. 2023;10(3):215.","journal-title":"Separations"},{"issue":"13","key":"2896_CR84","doi-asserted-by":"publisher","first-page":"1341140","DOI":"10.1063\/5.0018516","volume":"153","author":"S P\u00e1ll","year":"2020","unstructured":"P\u00e1ll S, Zhmurov A, Bauer P, Abraham M, Lundborg M, Gray A, et al. Heterogeneous parallelization and acceleration of molecular dynamics simulations in GROMACS. J Chem Phys. 2020;153(13):1341140.","journal-title":"J Chem Phys"},{"key":"2896_CR85","unstructured":"Cheng Z. Discovery of inhibitors targeting p38\u03b3 and PLK1 using combined virtual screening, molecular dynamics simulations and biological evaluation; 2024. Doctoral dissertation, Swinburne"},{"issue":"4","key":"2896_CR86","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/cbdd.13446","volume":"93","author":"M Ahinko","year":"2019","unstructured":"Ahinko M, Niinivehmas S, Jokinen E, Pentik\u00e4inen OT. Suitability of MMGBSA for the selection of correct ligand binding modes from docking results. Chem Biol Drug Des. 2019;93(4):522\u201338.","journal-title":"Chem Biol Drug Des"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02896-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-02896-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02896-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:03:03Z","timestamp":1762426983000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-02896-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":86,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["2896"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-02896-x","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,11]]},"assertion":[{"value":"13 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors (s) declare no potential conflict of interest concerning the research, authorship, and\/or publication of this article","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Infornmed consent"}}],"article-number":"469"}}